
From Kansas to Mission Bay: An interview with Professional in Residence Timothy Day
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In an interview with graduate student Leah Gulyas, Day traced his path to entrepreneurship from growing up in Kansas with the goal of pursuing medicine to…